Skip to content

    Lasa Supergenerics Limited

    Vertically integrated Active Pharmaceutical Ingredients (API) maker specialising in veterinary APIs (Albendazole, Fenbendazole, Oxfendazole, Ricobendazole) plus human APIs, animal feed ingredients and therapeutic reagents.

    Healthcare
    Healthcare

    Overview

    Price

    Market Cap

    ₹36 Cr

    Sector

    Healthcare

    Healthcare

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital4141505050505050
    Reserves10111810868473460
    Borrowings48192022222710
    Other Liabilities42293124321687
    Total Liabilities2322082091641511027266
    AssetsFixed Assets152143137119110685855
    CWIP00553000
    Investments00000000
    Other Assets8065674039331311
    Total Assets2322082091641511027266

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating4114419-172-30
    Cash from Investing-7-2-4-311080
    Cash from Financing-33-10-360-4-2-60
    SummaryCapital Expenditure
    Free Cash Flow29133512-12050
    FCF Margin

    Valuation

    Too capital-hungry for an earnings DCF

    For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.

    LASA · CAPITAL_INTENSIVE

    Learn to analyse Lasa Supergenerics Limited

    Guides on how to read this kind of business and the numbers that matter.